Associated Genetic Biomarkers
There is 1 clinical trial for oral neoplasm, of which 1 is open and 0 are completed or closed. Of the trial that contains oral neoplasm as an inclusion criterion, 1 is phase 2 (1 open).
del(11)(p10), del(13)(q10), and del(17)(p10) are the most frequent gene inclusion criteria for oral neoplasm clinical trials .
Avelumab is the most common intervention in oral neoplasm clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.